Synapse

← BMJ

Papers in BMJ

Page 7 · newest first

  1. Clinical updates: Assessment and management of suicidal ideation in adultsBMJ · 2026
  2. Bad influencers: How social media imported US-style drug advertising to the UKBMJ · 2026
  3. Valdo Calocane inquiry offers valuable lessons for overhauling mental health servicesBMJ · 2026
  4. Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR)BMJ · 2026
  5. Adapting health systems for water bankruptcyBMJ · 2026
  6. When I use a word . . . The Devil’s Medical DictionaryBMJ · 2026
  7. Detrimental effects of conflicts of interest in GLP-1 therapy guidanceBMJ · 2026
  8. Data sharing must evolve towards data sovereigntyBMJ · 2026
  9. Maximising the benefits of mandatory calorie menu labelling in EnglandBMJ · 2026
  10. Breaking down barriers to medical training - the resident doctor who helps students meet their potentialBMJ · 2026
  11. Obesity versus China: how Ozempic is complicating the world’s largest weight loss campaignBMJ · 2026
  12. Advances in the development of malaria vaccinesBMJ · 2026
  13. American Diabetes Association controversy: Activism is necessary to protect scientific freedomBMJ · 2026
  14. Why not screening for prostate cancer is justifiedBMJ · 2026
  15. UK Biobank: Confidential patient health details still online three months after leaks, BMJ findsBMJ · 2026
  16. Fitness to practice tribunals for sexual misconduct are unfit for purposeBMJ · 2026
  17. Reporting of Cohort and Routinely Collected Data in Randomised Controlled Trial Protocols (SPIRIT-ROUTINE): extension checklist with explanation and elaborationBMJ · 2026
  18. Updated International Patient Decision Aid Standards (IPDAS version 5.0): modified Delphi, evidence informed consensus processBMJ · 2026
  19. Influence on regulatory decisions for drugs with limited evidenceBMJ · 2026
  20. Ditching the smartphone: how one GP swapped doom scrolling for improved focus and productivityBMJ · 2026
  21. Prisons: A missing front in England’s HIV action planBMJ · 2026
  22. The limits of reporting checklists in paediatric researchBMJ · 2026
  23. Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK)BMJ · 2026
  24. Trump's gold standard science is harming US science and healthBMJ · 2026
  25. A London Lark Rising : the story of the people and places of the East India CompanyBMJ · 2026
  26. Rammya Mathew: The sleep fairy scandal is a wake-up call for public healthBMJ · 2026
  27. Nicotine as a wellness product? The smoking alternatives being pushed by big tobaccoBMJ · 2026
  28. Advances in supporting development in autistic children and youthBMJ · 2026
  29. DRC has strengthened its response to Ebola - but conflict and funding cuts are testing its capacityBMJ · 2026
  30. Nottingham attacks inquiry: what we learnt, and what families want nextBMJ · 2026
  31. What Your Patient is Thinking: Compassion on the journey to a dementia diagnosisBMJ · 2026
  32. My colleague made a derogatory comment about a patient - what now?BMJ · 2026
  33. AI warfare demands a new era of humanitarian lawBMJ · 2026
  34. Middle powers must collaborate on health data and health AI is imperativeBMJ · 2026
  35. The peace pill: an overdue prescription for the Eastern Mediterranean RegionBMJ · 2026
  36. Advances in the management of ADHD in children and adolescentsBMJ · 2026
  37. Will AI do more harm than good to the UK's mental health?BMJ · 2026
  38. Improving ADHD care pathways should be prioritised for children and young peopleBMJ · 2026
  39. After remarkable progress, newborn, child, and adolescent survival is now at riskBMJ · 2026
  40. Systematic estimates of global causes of neonatal and under 5 mortality in 2000-24: secondary data analysis using bayesian multinomial logistic regressionBMJ · 2026
  41. Estimates of global causes of death for children and adolescents aged 5-19 in 2000-24: secondary data analysis using bayesian multinomial logistic regressionBMJ · 2026
  42. Global, regional, and national levels and trends in under 5, infant, and neonatal mortality during 1990-2024 with scenario based projections to 2030: modelling studyBMJ · 2026
  43. Global, regional, and national levels and trends in older child, adolescent, and youth (5-24 years) all cause mortality from 1990 to 2024: modelling studyBMJ · 2026
  44. Designer peptides for wellness: are they safe?BMJ · 2026
  45. Six ways Gavi will continue to immunise half the world's children amid vaccine backlash and a funding crisisBMJ · 2026
  46. Using routinely collected data for research purposes: challenges and mitigation strategiesBMJ · 2026
  47. Satisfaction with the NHS is rising—so why are people still so unhappy with it?BMJ · 2026
  48. Helen Salisbury: Goodbye, Mr StreetingBMJ · 2026
  49. UK National Screening Committee position statement on surrogate outcomes in cancer screening trialsBMJ · 2026
  50. Enhanced Games: Bold claims, weak evidence, and serious risksBMJ · 2026